Allogene Therapeutics, Inc. (ALLO)
1.70
+0.06
(+3.66%)
USD |
NASDAQ |
Jan 14, 16:00
1.71
+0.01
(+0.59%)
After-Hours: 20:00
Allogene Therapeutics Market Cap: 382.04M for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.910B |
| AIM ImmunoTech, Inc. | 3.854M |
| Perspective Therapeutics, Inc. | 194.77M |
| Protalix Biotherapeutics, Inc. | 165.67M |
| Armata Pharmaceuticals, Inc. | 207.08M |
Market Cap Related Metrics
| Price to Book Value | 1.212 |
| Price | 1.70 |
| Earnings Yield | -57.71% |